Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

crd

  • Home
  •  
  • crd



  • Most Read
  • Latest Comments
  • Rewardle enters medtech space, continues portfolio growth with equity-for-fees
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Rewardle enters medtech space, continues portfolio growth with equity-for-fees
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Rewardle enters medtech space, continues portfolio growth with equity-for-fees
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Rewardle enters medtech space, continues portfolio growth with equity-for-fees
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Rewardle enters medtech space, continues portfolio growth with equity-for-fees
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Respiri and Echo IQ team up to expand into the US with heart disease detection and remote post-consultation care
    Respiri and Echo IQ team up to expand into the US with heart disease detection and remote post-consultation care
    • News

  • Digital Human platform building momentum as UNITH signs its most clients in September quarter
    Digital Human platform building momentum as UNITH signs its most clients in September quarter
    • News

  • Rewardle enters the microinvesting space with bargain Upstreet buy
    Rewardle enters the microinvesting space with bargain Upstreet buy
    • News

  • Rewardle to expand food delivery business with acquisition of YourGrocer for $2,898
    Rewardle to expand food delivery business with acquisition of YourGrocer for $2,898
    • News

  • Respiri hoping asthma sufferers will pay $20 a month for this
    Respiri hoping asthma sufferers will pay $20 a month for this
    • News

  • Rewardle enters medtech space, continues portfolio growth with equity-for-fees
    • News

    Rewardle enters medtech space, continues portfolio growth with equity-for-fees

    Marketing tech company Rewardle (ASX: RXH) is quickly building up a unique portfolio of small businesses where the company is backing themselves to lift their customers’ business so much that they have again secured equity options in lieu of their service fees. This time, it’s with medtech company Cardiac Rhythm Diagnostics.  Both Rewardle and Cardiac

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.